Furthermore, the results of this large-scale study expand and confirm our previous finding of TFF3 promoter hypomethylation in PC, which was based only on a small patient sample set (10 PC vs. 12 BPH) [36]. Here, TFF3 is linked to benign prostatic hyperplasia.